Literature DB >> 23695557

Structure of the catalytic domain of the Tannerella forsythia matrix metallopeptidase karilysin in complex with a tetrapeptidic inhibitor.

Tibisay Guevara1, Miroslaw Ksiazek, Peter Durand Skottrup, Núria Cerdà-Costa, Sergio Trillo-Muyo, Iñaki de Diego, Erik Riise, Jan Potempa, F Xavier Gomis-Rüth.   

Abstract

Karilysin is the only metallopeptidase identified as a virulence factor in the odontopathogen Tannerella forsythia owing to its deleterious effect on the host immune response during bacterial infection. The very close structural and sequence-based similarity of its catalytic domain (Kly18) to matrix metalloproteinases suggests that karilysin was acquired by horizontal gene transfer from an animal host. Previous studies by phage display identified peptides with the consensus sequence XWFPXXXGGG (single-letter amino-acid codes; X represents any residue) as karilysin inhibitors with low-micromolar binding affinities. Subsequent refinement revealed that inhibition comparable to that of longer peptides could be achieved using the tetrapeptide SWFP. To analyze its binding, the high-resolution crystal structure of the complex between Kly18 and SWFP was determined and it was found that the peptide binds to the primed side of the active-site cleft in a substrate-like manner. The catalytic zinc ion is clamped by the α-amino group and the carbonyl O atom of the serine, thus distantly mimicking the general manner of binding of hydroxamate inhibitors to metallopeptidases and contributing, together with three zinc-binding histidines from the protein scaffold, to an octahedral-minus-one metal-coordination sphere. The tryptophan side chain penetrates the deep partially water-filled specificity pocket of Kly18. Together with previous serendipitous product complexes of Kly18, the present results provide the structural determinants of inhibition of karilysin and open the field for the design of novel inhibitory strategies aimed at the treatment of human periodontal disease based on a peptidic hit molecule.

Entities:  

Keywords:  inhibition; metalloproteinases; peptides

Mesh:

Substances:

Year:  2013        PMID: 23695557      PMCID: PMC3660881          DOI: 10.1107/S1744309113007392

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  23 in total

1.  "Red complex" (Bacteroides forsythus, Porphyromonas gingivalis, and Treponema denticola) in endodontic infections: a molecular approach.

Authors:  I N Rôças; J F Siqueira; K R Santos; A M Coelho
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2001-04

2.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

Review 3.  Matrix metalloproteinases: fold and function of their catalytic domains.

Authors:  Cynthia Tallant; Aniebrys Marrero; F Xavier Gomis-Rüth
Journal:  Biochim Biophys Acta       Date:  2009-04-15

4.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

Review 5.  Virulence mechanisms of Tannerella forsythia.

Authors:  Ashu Sharma
Journal:  Periodontol 2000       Date:  2010-10       Impact factor: 7.589

6.  Integration, scaling, space-group assignment and post-refinement.

Authors:  Wolfgang Kabsch
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-01-22

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

Review 8.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

9.  MolProbity: all-atom structure validation for macromolecular crystallography.

Authors:  Vincent B Chen; W Bryan Arendall; Jeffrey J Headd; Daniel A Keedy; Robert M Immormino; Gary J Kapral; Laura W Murray; Jane S Richardson; David C Richardson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-12-21

10.  A phage display selected 7-mer peptide inhibitor of the Tannerella forsythia metalloprotease-like enzyme Karilysin can be truncated to Ser-Trp-Phe-Pro.

Authors:  Peter Durand Skottrup; Grete Sørensen; Miroslaw Ksiazek; Jan Potempa; Erik Riise
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more
  6 in total

1.  Myroilysin Is a New Bacterial Member of the M12A Family of Metzincin Metallopeptidases and Is Activated by a Cysteine Switch Mechanism.

Authors:  Dongqing Xu; Jiale Zhou; Xiangdi Lou; Jianhua He; Tingting Ran; Weiwu Wang
Journal:  J Biol Chem       Date:  2017-02-09       Impact factor: 5.157

2.  An IgY-based immunoassay to evaluate the biomarker potential of the Tannerella forsythia virulence factor karilysin in human saliva.

Authors:  Peter Durand Skottrup; Rodrigo López; Miroslaw Ksiazek; Peter Højrup; Vibeke Baelum; Jan Potempa; Jakub Zbigniew Kaczmarek
Journal:  J Immunol Methods       Date:  2019-03-14       Impact factor: 2.303

Review 3.  Architecture and function of metallopeptidase catalytic domains.

Authors:  Núria Cerdà-Costa; Francesc Xavier Gomis-Rüth
Journal:  Protein Sci       Date:  2014-02       Impact factor: 6.725

4.  A novel mechanism of latency in matrix metalloproteinases.

Authors:  Mar López-Pelegrín; Miroslaw Ksiazek; Abdulkarim Y Karim; Tibisay Guevara; Joan L Arolas; Jan Potempa; F Xavier Gomis-Rüth
Journal:  J Biol Chem       Date:  2015-01-02       Impact factor: 5.157

5.  KLIKK proteases of Tannerella forsythia: putative virulence factors with a unique domain structure.

Authors:  Miroslaw Ksiazek; Danuta Mizgalska; Sigrum Eick; Ida B Thøgersen; Jan J Enghild; Jan Potempa
Journal:  Front Microbiol       Date:  2015-04-21       Impact factor: 5.640

6.  Structure-based mechanism of cysteine-switch latency and of catalysis by pappalysin-family metallopeptidases.

Authors:  Tibisay Guevara; Arturo Rodriguez-Banqueri; Miroslaw Ksiazek; Jan Potempa; F Xavier Gomis-Rüth
Journal:  IUCrJ       Date:  2020-01-01       Impact factor: 4.769

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.